US Patent Issued to INIPHARM on Feb. 18 for "Dichlorophenol HSD17B13 inhibitors and uses thereof" (American, Indian Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,489, issued on Feb. 18, was assigned to INIPHARM INC. (Bellevue, Calif.).

"Dichlorophenol HSD17B13 inhibitors and uses thereof" was invented by Sampath Kumar Anandan (Fremont, Calif.), Joshua Odingo (Bothell, Wash.), Heather Kay Webb Hsu (Seattle), Vincent Florio (Seattle), Subramanyam Janardhan Tantry (Bangalore, India) and Athisayamani Jeyaraj Duraiswamy (Bangalore, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, ...